99MTechnetium-fibrinogen labeling using electrolytic zircuronium release
Hebestreit, H.P.; Pryss, C.
Nuclear-Medizin 14(2): 172-184
1975
ISSN/ISBN: 0029-5566 PMID: 1178516 Document Number: 88500
An electrolytic method for labelling fibrinogen with zirconium as a reductant for 99mTc is presented. The optimal labelling conditions and the in-vitro screening are subject of the study. First clinical experience indicates that the substance is clottable in vivo and applicable for localization.
Document emailed within 1 workday
Related Documents
Richter, M.; Cyranka, U.; Markwardt, F. 1990: I-125 labeling of human, rat, and bovine fibrinogen Die Pharmazie 45(3): 200-203Bulychev, E.I.; Malysheva, A.I. 1972: Effect of conditions of labeling fibrinogen with radioactive I-131 on preservation of its native properties Voprosy Meditsinskoi Khimii 18(3): 305-309
Princen, H.M.; Moshage, H.J.; Emeis, J.J.; de Haard, H.J.; Nieuwenhuizen, W.; Yap, S.H. 1985: Fibrinogen fragments X, Y, D and e increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats Thrombosis and Haemostasis 53(2): 212-215
Hofmann, V.; Gati, W.P.; Straub, P.W. 1979: Fibrinogen Zurich I: impaired release of fibrinopeptide a Thrombosis and Haemostasis 41(4): 709-713
Meh, D.A.; Siebenlist, K.R.; Bergtrom, G.; Mosesson, M.W. 1995: Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin Journal of Laboratory and Clinical Medicine 125(3): 384-391
Borrell, M.; Vila, L.; Solá, J.; Coll, I.; Gómez, N.; González, N.; Rutllant, M.L. 1987: Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II Thrombosis Research 45(5): 591-599
Kubisz, P.; Holan, J.; Suranová, J.; Stránska, M. 1975: Bovine fibrinogen-induced 14C-serotonin and other compounds release from human blood platelets Folia Haematologica 102(6): 679-689
Rochette, L.; Bralet, J. 1975: Rates of endogenous noradrenaline release in rat brain, heart and intestines: comparison of results obtained after biosynthesis inhibition and 3H-tyrosine labeling Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 169(1): 80-85
Boutonnat, J.; Barbier, M.; Ronot, X.; Seigneurin, D. 2000: Nucleus labeling or membrane labeling for studying the proliferation of drug treated cells? Morphologie: Bulletin de l'Association des Anatomistes 84(265): 11-15
2014: Food labeling; nutrition labeling of standard menu items in restaurants and similar retail food establishments. Final rule Federal Register 79(230): 71155-71259
Dube, R.K.; Sahaa, P.K.; Dube, B.; Katiyar, B.C.; Rao, P.V. 1980: Fibrinogen, fibrinogen degradation products and fibrinolytic activity in cerebrospinal fluid in stroke Indian Journal of Medical Research 72: 454-457
Krause, W.H.; Maus, W. 1975: The transformation fibrinogen-fibrin in umbilical cord blood. a contribution to fetal fibrinogen Die Medizinische Welt 26(48): 2172-2174
Snowden, C.; Houlston, R.; Laker, M.F.; Kesteven, P.; Alberti, K.G.; Humphries, S.E. 1992: Plasma fibrinogen levels and fibrinogen genotype in non-insulin dependent diabetics Disease Markers 10(3): 159-167
Soria, J.; Soria, C.; Boulard, C. 1976: Action on human fibrinogen of anti-sera against fibrinogen dissociated chains Pathologie-Biologie 24 Suppl: 11-14
Oosthuizen, W.; Vorster, H.H.; Jerling, J.C.; Barnard, H.C.; Smuts, C.M.; Silvis, N.; Kruger, A.; Venter, C.S. 1994: Both fish oil and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels Thrombosis and Haemostasis 72(4): 557-562
Seydewitz, H.H.; Gram, J.; Bruhn, H.D.; Witt, I. 1991: Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 2(4): 501-506
Liu, Y.; Pan, J.; Wang, S.; Li, X.; Huang, Y. 2002: Beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients Chinese Medical Journal 115(2): 214-216
Lehmer, R.R.; Elias, A.N.; Capdeville, M.J.; Brown, D.R.; Branson, H.E. 1985: Fibrinogen Irvine: a qualitatively abnormal fibrinogen associated with the predisposition to recurrent visceral and peripheral venous thrombosis Journal of the National Medical Association 77(7): 561-565
Saoji, A.M.; Gupta, V.L.; Dubey, G.K.; Raichur, B.S. 1983: Demonstration of MISFi (molecules immunologically similar to fibrinogen) and fibrinogen antibody in various pathological studies using counter immunoelectrophoresis Indian Journal of Pathology and Microbiology 26(2): 89-98
Simon, B.; Schneider, J. 1970: Comparative studies on the accuracy of the fibrinogen-polymerisation-time-test. a method of fibrinogen estimation for use in clinic and practice Arztliche Forschung 24(8): 234-239